Feed BIAF
BI

bioAffinity Technologies, Inc. Common Stock

BIAF · NASDAQ

$6.06 -1.54% (-$0.10)
1M -52.58%
Market Cap $2.57M
P/E Ratio -
Div. Yield -
ROE 257.27%
Analiză

Un raport AI despre afacere, finanțe, evaluare, sentiment, știri și riscuri - scris în câteva minute.

Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.44x
P/B 0.68x
P/E N/A
Growth
78 /100
Growing
Rev. growth 986.60%
Book val. growth 12.98%
EPS growth N/A
Profitability
0 /100
Weak
Gross margin 39.57%
Net margin 257.33%
Op. margin 209.82%
Quality
10 /100
Poor
ROIC 238.03%
ROE 257.27%
ROA 199.30%
Debt
59 /100
Moderate
Debt/Equity 0.38x
Current ratio 1.44x
Int. coverage -337.54x
Stability
38 /100
Moderate
Beta -1.12x
Rev. volatility 30,310.85%
EPS volatility 22.74%

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre BIAF
Online

Despre companie

bioAffinity Technologies, Inc. specializes in developing diagnostic tests for the detection of cancer and other serious diseases. Their main product is CyPath® Lung, which is designed to detect lung cancer by analyzing cell samples from the respiratory tract. This non-invasive test can provide a quick and reliable diagnosis of lung cancer, enabling doctors to initiate treatment promptly and improve patients' chances of successful recovery. bioAffinity Technologies, Inc. is committed to innovative research and development of new diagnostic methods that can enhance cancer detection and save lives. Shares of bioAffinity Technologies, Inc. Common Stock may be attractive to investors seeking opportunities in biotechnology and healthcare innovations.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Maria Zannes

Employees

57

Headquarters

San Antonio

Evenimente viitoare

18 NOV.

Earnings

Upcoming earnings report

46d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.